Alibaba Health, Sinovac in deal to build platform for coronavirus vaccine inoculation
Alibaba Health Information Technology said on Thursday it has signed a strategic cooperation agreement with Chinese coronavirus vaccine developer Sinovac Biotech.
Alibaba Health Information Technology said on Thursday it has signed a strategic cooperation agreement with Chinese coronavirus vaccine developer Sinovac Biotech. The two firms will jointly build a platform for coronavirus vaccine inoculation in the future, Alibaba Health said in Chinese social media platform Weibo, without giving further details.
Sinovac's coronavirus vaccine candidate CoronaVac, being tested in final-stage large-scale trials in Brazil, Indonesia and Turkey, has already been given to tens of thousands of people via an emergency use program China launched in July. They include around 90% of the firm's employees and their families.
The two firms will also cooperate in broader areas including online booking of vaccines and post-vaccination health condition follow-up, Alibaba Health said.
ALSO READ
-
IDB Approves $243m to Bring More Reliable Power to Brazil’s Santa Catarina
-
Brazil’s Tax Reform Gets IDB Loans for State Finances and Public Services
-
São Paulo’s $460M Ferry Overhaul Brings Electric Vessels and New Local Jobs
-
Brazil’s Paraíba Secures $50 Million to Build Stronger Water and Sanitation Services
-
AfDB and Brazil Deepen Mali Cooperation on Food, Jobs and Energy
Google News